Latest / Decera Clinical Education Oncology Podcast
Expert Insights on Key Data From ASH 2020 on Nonmalignant Hematologic Disorders
In this episode, Hanny Al-Samkari, MD; Sujit Sheth, MD; and Mark A. Schroeder, MD, provide their clinical perspectives on new data from ASH 2020 on nonmalignant hematologic disorders, with topics including:
Use of mycophenolate mofetil plus corticosteroids vs standard corticosteroid treatment in patients with ITP from the phase III FLIGHT study
Analysis of an ongoing phase I/II trial of rilzabrutinib reporting safety and efficacy in the long-term extension for adult patients with relapsed/refractory ITP
New data from the phase III HOPE-B study of etranacogene dezaparvovec gene therapy, using…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.